-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
-
Summary
-
Agios Pharmaceuticals, Inc. annual/quarterly Depreciation history and growth rate from Q1 2013 to Q1 2020.
- Agios Pharmaceuticals, Inc. Depreciation for the quarter ending March 31, 2020 was $2.47M, a 23.4% increase year-over-year.
- Agios Pharmaceuticals, Inc. annual Depreciation for 2023 was $6.6M, a 21.4% decline from 2022.
- Agios Pharmaceuticals, Inc. annual Depreciation for 2022 was $8.4M, a 4.55% decline from 2021.
- Agios Pharmaceuticals, Inc. annual Depreciation for 2021 was $8.8M, a 6.38% decline from 2020.
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)